Chapter 4 Clinical and Genetic Aspects of Spinocerebellar Ataxias with Emphasis on Polyglutamine Expansions

Blue Books of Neurology

Volumn 31, Issue C, 2007, Pages 113-144

  Stevanin, Giovanni ^a   Durr, Alexandra ^a   Brice, Alexis ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957147534     PISSN: 1877184X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1877-184X(09)70078-4     Document Type: Article

References (235)

1. Polo J.M., et al. Hereditary ataxias and paraplegias in Cantabria, Spain: An epidemiological and clinical study. Brain 114 (1991) 855-866
2. Hirayama K., et al. Spinocerebellar degenerations in Japan: a nationwide epidemiological and clinical study. Acta Neurol Scand 153 Suppl (1994) 1-22
3. van de Warrenburg B.P., et al. Spinocerebellar ataxias in the Netherlands: prevalence and age at onset variance analysis. Neurology 58 (2002) 702-708
4. Zortea M., et al. Prevalence of inherited ataxias in the province of Padua, Italy. Neuroepidemiology 23 (2004) 275-280
5. Muzaimi M.B., et al. Population based study of late onset cerebellar ataxia in south east Wales. J Neurol Neurosurg Psychiatry 75 (2004) 1129-1134
6. Orozco G., et al. Dominantly inherited olivopontocerebellar atrophy from eastern Cuba: clinical, neuropathological, and biochemical findings. J Neurol Sci 93 (1989) 37-50
7. Sequeiros J., and Coutinho P. Epidemiology and clinical aspects of Machado-Joseph disease. Adv Neurol 61 (1993) 139-153
8. Orr H.T., et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet 4 (1993) 221-226
9. Imbert G., et al. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Nature Genet 14 (1996) 285-291
10. Sanpei K., et al. Identification of the spinocerebellar ataxia type 2 gene using a direct identification of repeat expansion and cloning technique, DIRECT. Nature Genet 14 (1996) 277-284
11. Pulst S.M., et al. Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nature Genet 14 (1996) 269-276
12. Kawaguchi Y., et al. CAG expansion in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet 8 (1994) 221-227
13. Cancel G., et al. Marked phenotypic heterogeneity associated with expansion of a CAG repeat sequence at the spinocerebellar ataxia 3/Machado-Joseph disease locus. Am J Hum Genet 57 (1995) 809-816
14. Flanigan K., et al. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. Am J Hum Genet 59 (1996) 392-399
15. Chen D.H., et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 72 (2003) 839-849
16. Miyoshi Y., et al. A novel autosomal dominant spinocerebellar ataxia (SCA16) linked to chromosome 8q22.1-24.1. Neurology 57 (2001) 96-100
17. Koide R., et al. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease?. Hum Mol Genet 8 (1999) 2047-2053
18. Nakamura K., et al. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10 (2001) 1441-1448
19. Chung M.Y., et al. A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain 126 (2003) 1293-1299
20. Verbeek D.S., et al. Identification of a novel SCA locus (SCA19) in a Dutch autosomal dominant cerebellar ataxia family on chromosome region 1p21-q21. Hum Genet 111 (2002) 388-393
21. Knight M.A., et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain 127 (2004) 1172-1181
22. Vuillaume I., et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol 52 (2002) 666-670
23. van Swieten J.C., et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebellar ataxia [corrected]. Am J Hum Genet 72 (2003) 191-199
24. David G., et al. Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nature Genet 17 (1997) 65-70
25. Koob M.D., et al. Rapid cloning of expanded trinucleotide repeat sequences from genomic DNA. Nature Genet 18 (1998) 72-75
26. Del-Favero J., et al. Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. Hum Mol Genet 7 (1998) 177-186
27. Ranum L.P., et al. Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. Nature Genet 8 (1994) 280-284
28. 1A-voltage-dependent calcium channel. Nature Genet 15 (1997) 62-69
29. Holmes S.E., et al. Expansion of a novel CAG trinucleotide repeat in the 5′ region of PPP2R2B is associated with SCA12. Nat Genet 23 (1999) 391-392
30. Worth P.F., et al. Autosomal dominant cerebellar ataxia type III: linkage in a large British family to a 7.6-cM region on chromosome 15q14-21.3. Am J Hum Genet 65 (1999) 420-426
31. Knight M.A., et al. Spinocerebellar ataxia type 15 (sca15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant. Neurobiol Dis 13 (2003) 147-157
32. Yu G.Y., et al. Spinocerebellar ataxia type 26 maps to chromosome 19p13.3 adjacent to. SCA6. Ann Neurol 57 (2005) 349-354
33. Zu L., et al. Mapping of a new autosomal dominant spinocerebellar ataxia to chromosome 22. Am J Hum Genet 64 (1999) 594-599
34. Herman-Bert A., et al. Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation. Am J Hum Genet 67 (2000) 229-235
35. Brkanac Z., et al. A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch Neurol 59 (2002) 1291-1295
36. Ishikawa K., et al. An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5′ untranslated region of the gene encoding a protein with spectrin repeat and rho guanine-nucleotide exchange-factor domains. Am J Hum Genet 77 (2005) 280-296
37. Verbeek D.S., et al. Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. Brain 127 (2004) 2551-2557
38. Schelhaas H.J., et al. SCA19 and SCA22: evidence for one locus with a worldwide distribution. Brain 127 (2004) E6
39. Harding A.E. Clinical features and classification of inherited ataxias. Adv Neurol 61 (1993) 1-14
40. Matsuura T., et al. Large expansion of the ATTCT pentnucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 26 (2000) 191-194
41. Brkanac Z., et al. Autosomal dominant sensory/motor neuropathy with ataxia (SMNA): linkage to chromosome 7q22-q32. Am J Med Genet 114 (2002) 450-457
42. Stevanin G., et al. Spinocerebellar ataxia with sensory neuropathy maps to the SCA25 locus on chromosome 2. Ann Neurol 55 (2004) 97-104
43. Koide R., et al. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat Genet 6 (1994) 9-13
44. Nagafuchi S., et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat Genet 6 (1994) 14-18
45. Stevanin G., et al. Screening for proteins with polyglutamine expansions in autosomal dominant cerebellar ataxias. Hum Mol Genet 5 (1996) 1887-1892
46. Brusco A., et al. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. Arch Neurol 61 (2004) 727-733
47. Koob M.D., et al. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia(SCA8). Nature Genet 21 (1999) 379-384
48. Dalski A., et al. Mutation analysis in the fibroblast growth factor 14 gene: frameshift mutation and polymorphisms in patients with inherited ataxias. Eur J Hum Genet 13 (2005) 118-120
49. Stevanin G., et al. Mutation in the catalytic domain of protein kinase C gamma and extension of the phenotype associated with spinocerebellar ataxia type 14. Arch Neurol 61 (2004) 1242-1248
50. van de Warrenburg B.P., et al. Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology 61 (2003) 1760-1765
51. Yabe I., et al. Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. Arch Neurol 60 (2003) 1749-1751
52. Verbeek D.S., et al. Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. Brain 128 (2005) 436-442
53. Chen D.H., et al. The clinical and genetic spectrum of spinocerebellar ataxia 14. Neurology 64 (2005) 1258-1260
54. Klebe S., et al. New mutations in protein kinase C gamma associated with spinocerebellar ataxia type 14. Ann Neurol 58 (2005) 720-729
55. Seki T., et al. Mutant protein kinase C gamma found in spinocerebellar ataxia type 14 is susceptible to aggregate and cause cell death. J Biol Chem 280 (2005) 29096-29106
56. Ikeda Y., et al. Spectrin mutations cause spinocerebellar ataxia 5. Nat Genet 38 (2006) 84-90
57. Waters M.F., et al. Mutations in the voltage-gated potassium channel KCNC3 cause degenerative and developmental CNS phenotypes. Nat Genet 38 (2006) 447-451
58. Moseley M.L., et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology 51 (1998) 1666-1671
59. Stevanin G., et al. Are (CTG)n expansions at the SCA8 locus rare polymorphisms?. Nature Genet 24 (2000) 213
60. Silveira I., et al. Trinucleotide repeats in 202 families with ataxia: a small expanded (CAG)n allele at the SCA17 locus. Arch Neurol 59 (2002) 623-629
61. Schols L., et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes?. Ann Neurol 42 (1997) 924-932
62. Rolfs A., et al. Clinical features and neuropathology of autosomal dominant spinocerebellar ataxia (SCA17). Ann Neurol 54 (2003) 367-375
63. Stevanin G., et al. Mutations in the FGF14 gene are not a major cause of spinocerebellar ataxia in Caucasians. Neurology 63 (2004) 936
64. Tsai H.F., et al. Analysis of trinucleotide repeats in different SCA loci in spinocerebellar ataxia patients and in normal population of Taiwan. Acta Neurol Scand 109 (2004) 355-360
65. Maruyama H., et al. Difference in disease-free survival curve and regional distribution according to subtype of spinocerebellar ataxia: a study of 1,286 Japanese patients. Am J Med Genet 114 (2002) 578-583
66. Matsumura R., et al. Frequency of spinocerebellar ataxia mutations in the Kinki district of Japan. Acta Neurol Scand 107 (2003) 38-41
67. Jiang H., et al. Frequency analysis of autosomal dominant spinocerebellar ataxias in mainland Chinese patients and clinical and molecular characterization of spinocerebellar ataxia type 6. Chin Med J (Engl) 118 (2005) 837-843
68. Tang B., et al. Frequency of SCA1, SCA2, SCA3/MJD, SCA6, SCA7, and DRPLA CAG trinucleotide repeat expansion in patients with hereditary spinocerebellar ataxia from Chinese kindreds. J Paediatr Child Health 57 (2000) 540-544
69. Saleem Q., et al. Molecular analysis of autosomal dominant hereditary ataxias in the Indian population: high frequency of SCA2 and evidence for a common founder mutation. Hum Genet 106 (2000) 179-187
70. Basu P., et al. Analysis of CAG repeats in SCA1, SCA2, SCA3, SCA6, SCA7 and DRPLA loci in spinocerebellar ataxia patients and distribution of CAG repeats at the SCA1, SCA2 and SCA6 loci in nine ethnic populations of eastern India. Hum Genet 106 (2000) 597-604
71. Sinha K.K., et al. Autosomal dominant cerebellar ataxia: SCA2 is the most frequent mutation in eastern India. J Neurol Neurosurg Psychiatry 75 (2004) 448-452
72. Storey E., et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet 95 (2000) 351-357
73. Bryer A., et al. The hereditary adult-onset ataxias in South Africa. J Neurol Sci 216 (2003) 47-54
74. Chakravarty A., and Mukherjee S.C. Autosomal dominant cerebellar ataxias in ethnic Bengalees in West Bengal-an Eastern Indian state. Acta Neurol Scand 105 (2002) 202-208
75. Srivastava A.K., et al. Molecular and clinical correlation in five Indian families with spinocerebellar ataxia 12. Ann Neurol 50 (2001) 796-800
76. Kim J.Y., et al. Molecular analysis of spinocerebellar ataxias in Koreans: frequencies and reference ranges of SCA1, SCA2, SCA3, SCA6, and SCA7. Mol Cells 12 (2001) 336-341
77. Verbeek D.S., et al. Haplotype study in Dutch SCA3 and SCA6 families: evidence for common founder mutations. Eur J Hum Genet 12 (2004) 441-446
78. Didierjean O., et al. Linkage disequilibrium at the SCA2 locus. J Med Genet 36 (1999) 415-417
79. Dichgans M., et al. Spinocerebellar ataxia type 6: evidence for a strong founder effect among German families. Neurology 52 (1999) 849-851
80. Stevanin G., et al. Linkage disequilibrium at the Machado-Joseph disease/spinal cerebellar ataxia 3 locus: evidence for a common founder effect in French and Portuguese-Brazilian families as well as a second ancestral Portuguese-Azorean mutation. Am J Hum Genet 57 (1995) 1247-1250
81. Stevanin G., et al. Multiple origins of the spinocerebellar ataxia 7 (SCA7) mutation revealed by linkage disequilibrium studies with closely flanking markers, including an intragenic polymorphism (G3145TG/A3145TG). Eur J Hum Genet 7 (1999) 889-896
82. Terasawa H., et al. A novel haplotype of spinocerebellar ataxia type 6 contributes to the highest prevalence in western Japan. Neurosci Lett 358 (2004) 107-110
83. Mittal U., et al. Founder haplotype for Machado-Joseph disease in the Indian population: novel insights from history and polymorphism studies. Arch Neurol 62 (2005) 637-640
84. Martins S., et al. Portuguese families with dentatorubro pallidoluysian atrophy (DRPLA) share a common haplotype of Asian origin. Eur J Hum Genet 11 (2003) 808-811
85. Filla A., et al. Spinocerebellar ataxia type 2 in southern Italy: a clinical and molecular study of 30 families. J Neurol 246 (1999) 467-471
86. Pareyson D., et al. Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes. J Neurol 246 (1999) 389-393
87. Gaspar C., et al. Ancestral origins of the Machado-Joseph disease mutation: a worldwide haplotype study. Am J Hum Genet 68 (2001) 523-528
88. Stevanin G., et al. Linkage disequilibrium between the spinocerebellar ataxia 3/Machado-Joseph disease mutation and two intragenic polymorphisms, one of which, X359Y, affects the stop codon. Am J Hum Genet 60 (1997) 1548-1552
89. Jonasson J., et al. Evidence for a common spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia. Eur J Hum Genet 8 (2000) 918-922
90. Leber I., et al. Prevalence of dentatorubral-pallidoluysian atrophy in a large series of white patients with cerebellar ataxia. Archives of Neurology 60 (2003) 1097-1099
91. Teive H.A., et al. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology 63 (2004) 1509-1512
92. Rasmussen A., et al. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol 50 (2001) 234-239
93. Fujigasaki H., et al. SCA12 is a rare locus for autosomal dominant cerebellar ataxia: a study of an Indian family. Ann Neurol 49 (2001) 117-121
94. Cellini E., et al. A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia. Arch Neurol 59 (2002) 1952-1953
95. Ikeda Y., et al. Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan. Neurology 54 (2000) 950-955
96. Schols L., et al. Do CTG expansions at the SCA8 locus cause ataxia?. Ann Neurol 54 (2003) 110-115
97. Worth P.F., et al. Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nature Genet 24 (2000) 214-215
98. Sulek A., et al. SCA8 repeat expansion coexists with SCA1-not only with SCA6. Am J Hum Genet 73 (2003) 972-974
99. Sobrido M.J., et al. SCA8 repeat expansions in ataxia: a controversial association. Neurology 57 (2001) 1310-1312
100. Vincent J.B., et al. Long repeat tracts at SCA8 in major psychosis. Am J Med Genet 96 (2000) 873-876
101. Verbeek D.S., et al. Gly118Asp is a SCA14 founder mutation in the Dutch ataxia population. Hum Genet 117 (2005) 88-91
102. La Spada A.R., et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
103. The Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72 (1993) 971-983
104. Jodice C., et al. Episodic ataxia type 2 (EA2) and spinocerebellar ataxia type 6 (SCA6) due to CAG repeat expansion in the CACNA1A gene on chromosome 19p. Hum Mol Genet 6 (1997) 1973-1978
105. Quan F., Janas J., and Popovich B.W. A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1. Hum Mol Genet 4 (1995) 2411-2413
106. Goldfarb L.G., et al. Unstable triplet repeat and phenotypic variability of spinocerebellar ataxia type 1. Ann Neurol 39 (1996) 500-506
107. Zuhlke C., et al. Spinocerebellar ataxia type 1 (SCA1): phenotype-genotype correlation studies in intermediate alleles. Eur J Hum Genet 10 (2002) 204-209
108. Yabe I., et al. SCA6 mutation analysis in a large cohort of the Japanese patients with late-onset pure cerebellar ataxia. J Neurol Sci 156 (1998) 89-95
109. van de Warrenburg B.P., et al. Striking anticipation in spinocerebellar ataxia type 7: the infantile phenotype. J Neurol 248 (2001) 911-914
110. Maltecca F., et al. Intergenerational instability and marked anticipation in SCA-17. Neurology 61 (2003) 1441-1443
111. Padiath Q.S., et al. Identification of a novel 45 repeat unstable allele associated with a disease phenotype at the MJD1/SCA3 locus. Am J Med Genet B Neuropsychiatr Genet 133 (2005) 124-126
112. Gu W., et al. The shortest expanded allele of the MJD1 gene in a Chinese MJD kindred with autonomic dysfunction. Eur Neurol 52 (2004) 107-111
113. Oda M., et al. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Arch Neurol 61 (2004) 209-212
114. Stevanin G., et al. Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain 126 (2003) 1599-1603
115. Cellini E., et al. Spinocerebellar ataxia type 17 repeat in patients with Huntington's disease-like and ataxia. Ann Neurol 56 (2004) 163-164
116. Nardacchione A., et al. Definition of the smallest pathological CAG expansion in SCA7. Clin Genet 56 (1999) 232-234
117. Stevanin G., et al. De novo expansion of intermediate alleles in spinocerebellar ataxia 7. Hum Mol Genet 7 (1998) 1809-1813
118. Zuhlke C., et al. Phenotypical variability of expanded alleles in the TATA-binding protein gene: reduced penetrance in SCA17?. J Neurol 250 (2003) 161-163
119. Zuhlke C., et al. Spinocerebellar ataxia type 17: report of a family with reduced penetrance of an unstable Gln49 TBP allele, haplotype analysis supporting a founder effect for unstable alleles and comparative analysis of SCA17 genotypes. BMC Med Genet 6 (2005) 27
120. Katayama T., et al. Nineteen CAG repeats of the SCA6 gene in a Japanese patient presenting with ataxia. J Neurol 247 (2000) 711-712
121. Matsuyama Z., et al. Molecular features of the CAG repeats of spinocerebellar ataxia 6 (SCA6). Hum Mol Genet 6 (1997) 1283-1287
122. Zuhlke C., et al. Different types of repeat expansion in the TATA-binding protein gene are associated with a new form of inherited ataxia. Eur J Hum Genet 9 (2001) 160-164
123. Stevanin G., Durr A., and Brice A. Clinical and molecular advances in autosomal dominant cerebellar ataxias: from genotype to phenotype and physiopathology. Eur J Hum Genet 8 (2000) 4-18
124. Stevanin G., Durr A., and Brice A. Spinocerebellar ataxias caused by polyglutamine expansions. Adv Exp Med Biol 516 (2002) 47-77
125. Komure O., et al. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology 45 (1995) 143-149
126. Warner T.T., et al. A clinical and molecular genetic study of dentatorubropallidoluysian atrophy in four European families. Ann Neurol 37 (1995) 452-459
127. Ikeuchi T., et al. Dentatorubral-pallidoluysian atrophy: clinical features are closely related to unstable expansions of trinucleotide (CAG) repeat. Ann Neurol 37 (1995) 769-775
128. Norremolle A., et al. Elongated CAG repeats of the B37 gene in a Danish family with dentatorubro-pallido-luysian atrophy. Hum Genet 95 (1995) 313-318
129. Kang S., et al. Expansion and deletion of CTG repeats from human disease genes are determined by the direction of replication in E. coli(SCA6). Nature Genet 10 (1995) 213-218
130. Igarashi S., et al. Intergenerational instability of the CAG repeat of the Machado-Joseph disease (MJD1) is affected by the genotype of the normal chromosome: implications for the molecular mechanisms of the instability of the CAG repeat. Hum Mol Genet 5 (1996) 923-932
131. Takiyama Y., et al. Single sperm analysis of the CAG repeats in the gene for Machado-Joseph disease (MJD1): evidence for non-Mendelian transmission of the MJD1 gene and for the effect of the intragenic CGG/GGG polymorphism on the intergenerational instability. Hum Mol Genet 6 (1997) 1063-1068
132. Libby R.T., et al. Genomic context drives SCA7 CAG repeat instability while expressed SCA7 cDNAs are intergenerationally and somatically stable in transgenic mice. Hum Mol Genet 12 (2003) 41-50
133. Brock G.J., Anderson N.H., and Monckton D.G. Cis-Acting modifiers of expanded CAG/CTG triplet repeat expandability: associations with flanking GC content and proximity to CpG islands. Hum Mol Genet 8 (1999) 1061-1067
134. Monckton D.G., et al. Very large (CAG)(n) DNA repeat expansions in the sperm of two spinocerebellar ataxia type 7 males. Hum Mol Genet 8 (1999) 2473-2478
135. David G., et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet 7 (1998) 165-170
136. Cancel G., et al. Somatic mosaicism of the CAG repeat expansion in spinocerebellar ataxia type 3/Machado-Joseph disease. Human Mutation 11 (1998) 23-27
137. Ueno S., et al. Somatic mosaicism of CAG repeat in dentatorubral-pallidoluysian atrophy (DRPLA). Hum Mol Genet 4 (1995) 663-666
138. Lopes-Cendes I., et al. Somatic mosaicism in the central nervous system in spinocerebellar ataxia type 1 and Machado-Joseph disease. Ann Neurol 40 (1996) 199-206
139. Takano H., et al. Somatic mosaicism of expanded CAG repeats in brains of patients with dentatorubral-pallidoluysian atrophy: cellular population-dependent dynamics of mitotic instability. Am J Hum Genet 58 (1996) 1212-1222
140. Chong S.S., et al. Gametic and somatic tissue-specific heterogeneity of the expanded SCA1 CAG repeat in spinocerebellar ataxia type 1. Nature Genet 10 (1995) 344-350
141. Yanagisawa H., et al. A unique origin and multistep process for the generation of expanded DRPLA triplet repeats. Hum Mol Genet 5 (1996) 373-379
142. Takano H., et al. Close associations between prevalences of dominantly inherited spinocerebellar ataxias with CAG-repeat expansions and frequencies of large normal CAG alleles in Japanese and Caucasian populations. Am J Hum Genet 63 (1998) 1060-1066
143. Mittal U., et al. Post-zygotic de novo trinucleotide repeat expansion at spinocerebellar ataxia type 7 locus: evidence from an Indian family. J Hum Genet 50 (2005) 155-157
144. Bauer P., et al. Large de novo expansion of CAG repeats in patient with sporadic spinocerebellar ataxia type 7. J Neurol 251 (2004) 1023-1024
145. Shatunov A., et al. Small de novo duplication in the repeat region of the TATA-box-binding protein gene manifest with a phenotype similar to variant Creutzfeldt-Jakob disease. Clin Genet 66 (2004) 496-501
146. Ikeuchi T., et al. Spinocerebellar ataxia type 6: CAG repeat expansion in alpha1A voltage-dependent calcium channel gene and clinical variations in Japanese population. Ann Neurol 42 (1997) 879-884
147. Potter N.T., et al. Molecular and clinical findings in a family with dentatorubral-pallidoluysian atrophy. Ann Neurol 37 (1995) 273-277
148. Gomez C.M., et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 42 (1997) 933-950
149. Schols L., et al. Spinocerebellar ataxia type 6: genotype and phenotype in German kindreds. J Neurol Neurosurg Psychiatry 64 (1998) 67-73
150. Watanabe H., et al. Frequency analysis of autosomal dominant cerebellar ataxias in Japanese patients and clinical characterization of spinocerebellar ataxia type 6. Clin Genet 53 (1998) 13-19
151. Geschwind D.H., et al. Spinocerebellar ataxia type 6: frequency of the mutation and genotype-phenotype correlations. Neurology 49 (1997) 1247-1251
152. van de Warrenburg B.P., et al. Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol 57 (2005) 505-512
153. Durr A., et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular and neuropathological features. Ann Neurol 39 (1996) 490-499
154. Hayes S., et al. CAG repeat length in RAI1 is associated with age at onset variability in spinocerebellar ataxia type 2 (SCA2). Hum Mol Genet 9 (2000) 1753-1758
155. Pulst S.M., et al. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 128 (2005) 2297-2303
156. Chattopadhyay B., et al. Modulation of age at onset in Huntington's disease and spinocerebellar ataxia type 2 patients originated from eastern India. Neurosci Lett 345 (2003) 93-96
157. DeStefano A.L., et al. A familial factor independent of CAG repeat length influences age at onset of Machado-Joseph disease. Am J Hum Genet 59 (1996) 119-127
158. Durr A., and Brice A. Clinical and genetic aspects of spinocerebellar degeneration. Curr Opin Neurol 13 (2000) 407-413
159. Maciel P., et al. Correlation between CAG repeat length and clinical features in Machado-Joseph disease. Am J Hum Genet 57 (1995) 54-61
160. Durr A., et al. Phenotypic variability in autosomal dominant cerebellar ataxia type I is unrelated to genetic heterogeneity. Brain 116 (1993) 1497-1508
161. Sasaki H., et al. Clinical features and natural history of spinocerebellar ataxia type 1. Acta Neurol Scand 93 (1996) 64-71
162. Burk K., et al. Cognitive deficits in spinocerebellar ataxia type 1, 2, and 3. J Neurol 250 (2003) 207-211
163. Globas C., et al. The cerebellum and cognition: intellectual function in spinocerebellar ataxia type 6 (SCA6). J Neurol 250 (2003) 1482-1487
164. Giunti P., et al. Molecular and clinical study of 18 families with ADCA type II: evidence for genetic heterogeneity and de novo mutation. Am J Hum Genet 64 (1999) 1594-1603
165. Jodice C., et al. Effect of trinucleotide repeat length and parental sex on phenotypic variation in spinocerebellar ataxia I. Am J Hum Genet 54 (1994) 959-965
166. Yabe I., et al. Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6). J Neurol 250 (2003) 440-443
167. Dubourg O., et al. Analysis of the SCA1 CAG repeat in a large number of families with dominant ataxia: clinical and molecular correlations. Ann Neurol 37 (1995) 176-180
168. Cancel G., et al. Molecular and clinical correlations in spinocerebellar ataxia 2: a study of 32 families. Hum Mol Genet 6 (1997) 709-715
169. Martin J., et al. Spinocerebellar ataxia type 7 (SCA7): correlations between phenotype and genotype in one large Belgian family. J Neurol Sci 168 (1999) 37-46
170. Hagenah J.M., et al. Focal dystonia as a presenting sign of spinocerebellar ataxia 17. Mov Disord 19 (2004) 217-220
171. Filla A., et al. Early onset autosomal dominant dementia with ataxia, extrapyramidal features, and epilepsy. Neurology 58 (2002) 922-928
172. Fujigasaki H., et al. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Brain 124 (2001) 1939-1947
173. Bauer P., et al. Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington's disease-like phenotype. J Med Genet 41 (2004) 230-232
174. Toyoshima Y., et al. SCA17 homozygote showing Huntington's disease-like phenotype. Ann Neurol 55 (2004) 281-286
175. Wu Y.R., et al. Genetic testing in spinocerebellar ataxia in Taiwan: expansions of trinucleotide repeats in SCA8 and SCA17 are associated with typical Parkinson's disease. Clin Genet 65 (2004) 209-214
176. De Michele G., et al. Dementia, ataxia, extrapyramidal features, and epilepsy: phenotype spectrum in two Italian families with spinocerebellar ataxia type 17. Neurol Sci 24 (2003) 166-167
177. Wu Y.R., et al. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. J Neural Transm 112 (2005) 539-546
178. Belal S., et al. Clinical and genetic analysis of a Tunisian family with autosomal dominant cerebellar ataxia type 1 linked to the SCA2 locus. Neurology 44 (1994) 1423-1426
179. van de Warrenburg B.P., et al. Peripheral nerve involvement in spinocerebellar ataxias. J Paediatr Child Health 61 (2004) 257-261
180. Tuite P.J., et al. Dopa-responsive parkinsonism phenotype of Machado-Joseph disease: confirmation of 14q CAG expansion. Ann Neurol 38 (1995) 684-687
181. Lu C.S., et al. The parkinsonian phenotype of spinocerebellar ataxia type 3 in a Taiwanese family. Parkinsonism Relat Disord 10 (2004) 369-373
182. Subramony S.H., et al. Ethnic differences in the expression of neurodegenerative disease: Machado-Joseph disease in Africans and Caucasians. Mov Disord 17 (2002) 1068-1071
183. Wilder-Smith E., et al. Spinocerebellar ataxia type 3 presenting as an L-DOPA responsive dystonia phenotype in a Chinese family. J Neurol Sci 213 (2003) 25-28
184. Furtado S., et al. Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2). Mov Disord 19 (2004) 622-629
185. Lu C.S., et al. The parkinsonian phenotype of spinocerebellar ataxia type 2. J Paediatr Child Health 61 (2004) 35-38
186. Durr A., et al. Autosomal dominant cerebellar ataxia type I in Martinique (French West Indies): clinical and neuropathological analysis of 53 patients from three unrelated SCA2 families. Brain 118 (1995) 1573-1581
187. Sato K., et al. Does homozygosity advance the onset of dentatorubralpallidoluysian atrophy?. Neurology 45 (1995) 1934-1936
188. Sobue G., et al. Homozygosity for Machado-Joseph disease gene enhances phenotypic severity [letter]. J Neurol Neurosurg Psychiatry 60 (1996) 354-356
189. Squitieri F., et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. Brain 126 (2003) 946-955
190. Wu Y.R., et al. Dystonia as a presenting sign of spinocerebellar ataxia type 1. Mov Disord 19 (2004) 586-587
191. Stevanin G., et al. Clinical and molecular features of spinocerebellar ataxia type 6. Neurology 49 (1997) 1243-1246
192. Ansorge O., et al. Ataxin-7 aggregation and ubiquitination in infantile SCA7 with 180 CAG repeats. Ann Neurol 56 (2004) 448-452
193. Holmberg M., et al. Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 7 (1998) 913-918
194. Duyckaerts C., et al. Nuclear inclusions in spinocerebellar ataxia type 1. Acta Neuropathol (Berl) 97 (1999) 201-207
195. Cancel G., et al. Distribution of ataxin-7 in normal human brain and retina. Brain 123 (2000) 2519-2530
196. Einum D.D., et al. Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients. Neurogenetics 3 (2001) 83-90
197. Sisodia S.S. Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial?. Cell 95 (1998) 1-4
198. Bruni A.C., et al. Behavioral disorder, dementia, ataxia, and rigidity in a large family with TATA box-binding protein mutation. Arch Neurol 61 (2004) 1314-1320
199. Saudou F., et al. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95 (1998) 55-66
200. Klement I.A., et al. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95 (1998) 41-53
201. Katsuno M., et al. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35 (2002) 843-854
202. Takeyama K., et al. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35 (2002) 855-864
203. Helmlinger D., et al. Ataxin-7 is a subunit of GCN5 histone acetyltransferase-containing complexes. Hum Mol Genet 13 (2004) 1257-1265
204. Li F., et al. Ataxin-3 is a histone-binding protein with two independent transcriptional corepressor activities. J Biol Chem 277 (2002) 45004-45012
205. Shimohata T., et al. Expanded polyglutamine stretches interact with TAFII130, interfering with CREB-dependent transcription. Nat Genet 26 (2000) 29-36
206. Yue S., et al. The spinocerebellar ataxia type 1 protein, ataxin-1, has RNA-binding activity that is inversely affected by the length of its polyglutamine tract. Hum Mol Genet 10 (2001) 25-30
207. Irwin S., et al. RNA association and nucleocytoplasmic shuttling by ataxin-1. J Cell Sci 118 (2005) 233-242
208. Ralser M., et al. An integrative approach to gain insights into the cellular function of human ataxin-2. J Mol Biol 346 (2005) 203-214
209. Albrecht M., et al. Structural and functional analysis of ataxin-2 and ataxin-3. Eur J Biochem 271 (2004) 3155-3170
210. Ciosk R., DePalma M., and Priess J.R. ATX-2, the C. elegans ortholog of ataxin 2, functions in trans-lational regulation in the germline. Development 131 (2004) 4831-4841
211. La Spada A.R., et al. Polyglutamine-expanded ataxin-7 antagonizes crx function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31 (2001) 913-927
212. Okazawa H., et al. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34 (2002) 701-713
213. Lin X., et al. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci 3 (2000) 157-163
214. Serra H.G., et al. Gene profiling links SCA1 pathophysiology to glutamate signaling in Purkinje cells of transgenic mice. Hum Mol Genet 13 (2004) 2535-2543
215. Schaffar G., et al. Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol Cell 15 (2004) 95-105
216. Bennett E.J., et al. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 17 (2005) 351-365
217. Park Y., et al. Proteasome function is inhibited by polyglutamine-expanded ataxin-1, the SCA1 gene product. Mol Cells 19 (2005) 23-30
218. McMahon S.J., et al. Polyglutamine-expanded spinocerebellar ataxia-7 protein disrupts normal SAGA and SLIK histone acetyltransferase activity. Proc Natl Acad Sci USA 102 (2005) 8478-8482
219. Palhan V.B., et al. Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc Natl Acad Sci USA 102 (2005) 8472-8477
220. Strom A.L., Forsgren L., and Holmberg M. A role for both wild-type and expanded ataxin-7 in transcriptional regulation. Neurobiol Dis 20 (2005) 646-655
221. Reid S.J., et al. Molecular investigation of TBP allele length: a SCA17 cellular model and population study. Neurobiol Dis 13 (2003) 37-45
222. Iwabuchi K., et al. Autosomal dominant spinocerebellar degenerations: clinical, pathological, and genetic correlations. Rev Neurol (Paris) 155 (1999) 255-270
223. Koeppen A.H. The pathogenesis of spinocerebellar ataxia. Cerebellum 4 (2005) 62-73
224. Benton C.S., et al. Molecular and clinical studies in SCA7 define a broad clinical spectrum and the infantile phenotype. Neurology 51 (1998) 1081-1086
225. Mao R., et al. Childhood-onset ataxia: testing for large CAG-repeats in SCA2 and SCA7. Am J Med Genet 110 (2002) 338-345
226. Cagnoli C., et al. Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay. J Mol Diagn 6 (2004) 96-100
227. Cagnoli C., et al. Large pathogenic expansions in the SCA2 and SCA7 genes can be detected by fluorescent repeat-primed polymerase chain reaction. J Mol Diagn 8 (2006) 28-32
228. World Federation of Neurology Research Group on Huntington's Chorea. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 31 (1994) 555-559
229. Goizet C., Lesca G., and Durr A. Presymptomatic testing in Huntington's disease and autosomal dominant cerebellar ataxias. Neurology 59 (2002) 1330-1336
230. Lesca G., Goizet C., and Durr A. Predictive testing in the context of pregnancy: experience in Huntington's disease and autosomal dominant cerebellar ataxia. J Med Genet 39 (2002) 522-525
231. Abele M., et al. The aetiology of sporadic adult-onset ataxia. Brain 125 (2002) 961-968
232. Lee W.Y., et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 60 (2003) 858-863
233. Hagerman R.J., et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57 (2001) 127-130
234. Hagerman R.J., et al. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74 (2004) 1051-1056
235. Brussino A., et al. FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. Neurology 64 (2005) 145-147